About RenPharm
RenPharm is a Healthcare company based in Newton (United States) founded in 2016, and was acquired by LTS Lohmann in October 2025. Sterile and environmentally controlled pharmaceutical products are developed and manufactured. The company has 462 employees. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Founded in 2016 and based in Newton, United States, Renaissance operates in the pharmaceutical sector, focusing on contract development and manufacturing. Capabilities include production of injectable solutions, suspensions, ointments, gels, patches, and formulations for nasal, ophthalmic, and otic uses. Compliance is maintained with FDA, EMEA, and DEA standards across three cGMP facilities totaling 310,000 square feet.
- Headquarters Newton, United States
- Employees 462
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website renpharm.com
- Social LinkedIn
- Acquired by LTS Lohmann (Oct 2025)
- Investors
- Employee Count462
- Acquired byLTS Lohmann
(Oct 2025)
Investors in RenPharm
RenPharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LTS Lohmann.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug delivery systems targeting multiple disease indications are developed. | 1997 | ltslohmann.com | Caldwell, United States |
Investor details for RenPharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RenPharm
28 people are tracked at RenPharm (8 in leadership, 20 in team); the tracked headcount is 462.
| Name | Role | Group |
|---|---|---|
Brenda Vesey | VP, CHRO | Leadership |
Marci Cuccio | Executive Assistant To President & Chief Executive Officer | Leadership |
Kimberly Ernst | VP, Product Development & Laboratory Services | Leadership |
Serge Maltais | President & CEO | Leadership |
Al Atkinson | VP, Commercial Services & Supply Chain | Leadership |
Swagat Sangamnerkar | Director Of Manufacturing Science & Technology (msat & Validation) | Leadership |
Andy Thaw | Director Of Information Technology | Leadership |
Daniel O'Keefe | Director, Commercial Services | Leadership |
Jeffrey Steward | Sr. Manager Facilities And Critical Utilities | Team |
Cynthia Russo | Scientist I, Microbiologist | Team |
Brad Promisel | Information Technology Sr Business Systems Analyst | Team |
Danielle Vohrer | Project Manager | Team |
Anthony Richiuso | Scientist III | Team |
Debbie Keating | Accounts Receivable Manager | Team |
Conner Banasiak | Scientist I | Team |
Jay Patel | Principal Engineer - Technical Project Lead | Team |
John Morton | Senior Process Engineer | Team |
Jarrett Stapleton | Technical Operations Engineer | Team |
Jon Samms | Sr. Manager Manufacturing Science And Technology | Team |
Hersh Dharia | Senior Process Engineer | Team |
8 more people are available in the full profile.
Complete people profiles for RenPharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RenPharm
2 dated milestones of RenPharm across 9 years, from founding to its latest funding, stage changes and deals.
- Founded RenPharm is founded.
- Exit Acquired by LTS Lohmann.
Web traffic of RenPharm
The website of RenPharm (renpharm.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▼ 44.7% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as RenPharm (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Renpharm
Complete news archive for RenPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RenPharm
RenPharm was founded in 2016.
RenPharm is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
RenPharm has 462 employees.
Founded in 2016 and based in Newton, United States, Renaissance operates in the pharmaceutical sector, focusing on contract development and manufacturing. Capabilities include production of injectable solutions, suspensions, ointments, gels, patches, and formulations for nasal, ophthalmic, and otic uses. Compliance is maintained with FDA, EMEA, and DEA standards across three cGMP facilities totaling 310,000 square feet.
RenPharm has 1 investor. Key investors include LTS Lohmann.
Yes. RenPharm was acquired by LTS Lohmann in October 2025.